Syndax Pharmaceuticals's market cap is currently $1.25B. The company's EPS TTM is $-3.631; its P/E ratio is ―; Syndax Pharmaceuticals is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.86. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 139.71M	$ 1.52M	$ 1.52M
Gross Profit	$ -12.00K	$ -454.00K	$ 139.25M	$ 1.52M	$ 1.52M
Operating Income	$ -229.95M	$ -151.76M	$ 26.22M	$ -71.42M	$ -57.54M
EBITDA	$ -229.94M	$ -151.76M	$ 27.28M	$ -70.29M	$ -55.60M
Net Income	$ -209.36M	$ -143.75M	$ 24.93M	$ -73.07M	$ -55.95M
Balance Sheet
Cash & Short-Term Investments	$ 577.58M	$ 481.27M	$ 439.94M	$ 293.06M	$ 59.77M
Total Assets	$ 612.88M	$ 497.24M	$ 449.66M	$ 300.61M	$ 63.52M
Total Debt	$ 1.64M	$ 1.16M	$ 20.97M	$ 20.54M	$ 897.00K
Net Debt	$ -293.76M	$ -73.19M	$ -201.00M	$ -94.71M	$ -23.71M
Total Liabilities	$ 58.68M	$ 29.79M	$ 41.29M	$ 48.42M	$ 31.93M
Stockholders' Equity	$ 554.20M	$ 467.45M	$ 408.37M	$ 252.19M	$ 31.60M
Cash Flow
Free Cash Flow	$ -160.60M	$ -133.90M	$ 29.00M	$ -71.26M	$ -50.61M
Operating Cash Flow	$ -160.60M	$ -133.68M	$ 29.13M	$ -71.26M	$ -50.61M
Investing Cash Flow	$ 117.61M	$ -186.19M	$ -40.87M	$ -142.53M	$ 12.78M
Financing Cash Flow	$ 264.13M	$ 172.25M	$ 118.46M	$ 304.42M	$ 28.57M

Currency in USD

Syndax Pharmaceuticals Earnings and Revenue History

Income Statement >

Syndax Pharmaceuticals Debt to Assets

Balance Sheet >

Syndax Pharmaceuticals Cash Flow

Cash Flow >

Syndax Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing